Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
SARS-CoV-2: vaccines, convalescent plasma and other treatments … FDA bows to political pressure
New German „real world“ data: higher stroke frequency with new oral anticoagulants

NEW ON THE MARKET
Tafamidis (VYNDAQEL 61 mg) for cardiac transthyretin amyloidosis (short version)

THERAPY FROM A CRITICAL VIEWPOINT
Empagliflozin (JARDIANCE): second study with an SGLT2 inhibitor in heart failure
Rhythm or frequency control for atrial fibrillation: What is new?

BEWARE MISINFORMATION
Inactivated bifidobacteria (KIJIMEA REIZDARM PRO) for irritable bowel syndrome

IN BRIEF
Antithrombotic therapy after transcatheter aortic-valve implantation (TAVI)
Dexamethasone (FORTECORTIN, generics): European Medicines Agency supports use in COVID-19
SARS-CoV-2 vaccine: lack of transparency after trial interruption
Echinacea against SARS-CoV-2?  free article 
Ulipristal (ESMYA) for uterine myoma: withdrawal of marketing authorisation recommended

SIDE EFFECTS
Acute generalized exanthematous pustulosis with (val)aciclovir

e a-t ON THE INTERNET
Tafamidis (VYNDAQEL 61 mg) for cardiac transthyretin amyloidosis (long version)
Once again: on the substitution of original preparations with an application patent
© 2021 arznei-telegramm